GSK PLC (NYSE: GSK) Stock Price Target at $45: Argus Research
Global healthcare giant GSK PLC (NYSE: GSK) has received a BUY recommendation from Argus Research, with analysts projecting a 14% total return potential through June 2026. The $45 price target reflects confidence in the company's robust pipeline …